5901 - 5925 of 8654 Results
Title
Year
-
OPENTitle: An ankyrin repeat chaperone targets toxic oligomers during amyloidogenesisJournal Name: Protein SciencePublisher: WileyVol: 32Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pro.4728Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10367600Citation Count: 2
- Reaction-Based “Off–On” Fluorescent Probe Enabling Detection of Endogenous Labile Fe2+ and Imaging of Zn2+-induced Fe2+ Flux in Living Cells and Elevated Fe2+ in Ischemic Stroke2015RESTRICTEDTitle: Reaction-Based “Off–On” Fluorescent Probe Enabling Detection of Endogenous Labile Fe2+ and Imaging of Zn2+-induced Fe2+ Flux in Living Cells and Elevated Fe2+ in Ischemic StrokeJournal Name: Bioconjugate ChemistryPublisher: American Chemical Society (ACS)Vol: 27Issue #: 2Start Page: 302End Page: 308Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.5b00259Citation Count: 68
- NeuroBooster Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations2024OPENTitle: NeuroBooster Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse PopulationsJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 11Start Page: 2039End Page: 2048Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29902Best OA location URL: https://doi.org/10.1002/mds.29902Citation Count: 16
-
OPENTitle: Tau protein aggregation associated with SARS-CoV-2 main proteaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 18Issue #: 8Start Page: e0288138End Page: e0288138Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0288138Best OA location URL: https://doi.org/10.1371/journal.pone.0288138Citation Count: 11
- Network connectivity and local transcriptomic vulnerability underpin cortical atrophy progression in Parkinson’s disease2023OPENTitle: Network connectivity and local transcriptomic vulnerability underpin cortical atrophy progression in Parkinson’s diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 40Issue #:Start Page: 103523End Page: 103523Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2023.103523Best OA location URL: https://doi.org/10.1016/j.nicl.2023.103523Citation Count: 14
-
OPENTitle: A new biology of cell penetrating peptidesJournal Name: Peptide SciencePublisher: WileyVol: 113Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pep2.24154Best OA location URL: http://hdl.handle.net/2436/623251Citation Count: 7
-
RESTRICTEDTitle: The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?Journal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 2Start Page: 273End Page: 293Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29688Citation Count: 8
-
OPENTitle: Analysis of Heterozygous PRKN Variants and Copy‐Number Variations in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 178End Page: 187Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28299Citation Count: 45
- The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss2019OPENTitle: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron lossJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6592621Citation Count: 12
-
OPENTitle: PP1 Phosphatase Complexes: Undruggable No LongerJournal Name: CellPublisher: Elsevier BVVol: 174Issue #: 5Start Page: 1049End Page: 1051Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oa, elsevier-specific: oa user licenseDOI - Digital Object Identifier: 10.1016/j.cell.2018.08.007Best OA location URL: http://www.cell.com/article/S0092867418310237/pdfCitation Count: 11
-
OPENTitle: Genetic diversity of axon degenerative mechanisms in models of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 155Issue #:Start Page: 105368End Page: 105368Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105368Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105368Citation Count: 23
-
OPENTitle: Is REM Sleep Behavior Disorder Changing? Secular Changes Versus Referral PatternsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 10Start Page: 1519End Page: 1524Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mdc3.13842Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13842Citation Count: 2
- Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson’s disease2023OPENTitle: Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-023-45078-3Best OA location URL: https://www.nature.com/articles/s41598-023-45078-3.pdfCitation Count: 8
-
OPENTitle: PINK 1 autophosphorylation is required for ubiquitin recognitionJournal Name: EMBO reportsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embr.201744981Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embr.201744981Citation Count: 107
-
OPENTitle: Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesiaJournal Name: Neuroscience ResearchPublisher: Elsevier BVVol: 77Issue #: 4Start Page: 242End Page: 246Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neures.2013.10.002Citation Count: 48
- Generalization of deep learning models for ultra-low-count amyloid PET/MRI using transfer learning2020OPENTitle: Generalization of deep learning models for ultra-low-count amyloid PET/MRI using transfer learningJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 47Issue #: 13Start Page: 2998End Page: 3007Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00259-020-04897-6Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7680289Citation Count: 42
- Mitochondrial import stress and PINK1-mediated mitophagy: the role of the PINK1-TOMM-TIMM23 supercomplex2024RESTRICTEDTitle: Mitochondrial import stress and PINK1-mediated mitophagy: the role of the PINK1-TOMM-TIMM23 supercomplexJournal Name: AutophagyPublisher: Informa UK LimitedVol: 20Issue #: 8Start Page: 1903End Page: 1905Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/15548627.2024.2340399Citation Count: 8
-
OPENTitle: Cognitive Behavioral Therapy for Anxiety in Parkinsonʼs Disease: A Randomized Controlled TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2539End Page: 2548Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28533Best OA location URL: https://doi.org/10.1002/mds.28533Citation Count: 51
- Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: Gene and smoking status interaction2012RESTRICTEDTitle: Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: Gene and smoking status interactionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 72End Page: 76Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.07.007Best OA location URL: https://zenodo.org/record/3421671Citation Count: 26
-
OPENTitle: Urinary proteome profiling for stratifying patients with familial Parkinson’s diseaseJournal Name: EMBO Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 13Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/emmm.202013257Best OA location URL: https://doi.org/10.15252/emmm.202013257Citation Count: 129
-
OPENTitle: PKA-RII subunit phosphorylation precedes activation by cAMP and regulates activity terminationJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 217Issue #: 6Start Page: 2167End Page: 2184Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1083/jcb.201708053Best OA location URL: https://rupress.org/jcb/article-pdf/217/6/2167/1067112/jcb_201708053.pdfCitation Count: 49
-
OPENTitle: Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 55Issue #:Start Page: 92End Page: 96Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.05.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7850633Citation Count: 27
- Reply to letter to the editor “Adaptive DBS in Parkinson's disease: Headlines, perspectives and challenges”2019RESTRICTEDTitle: Reply to letter to the editor “Adaptive DBS in Parkinson's disease: Headlines, perspectives and challenges”Journal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 5Start Page: 1330End Page: 1331Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2019.06.014Citation Count: 0
-
OPENTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 UpdateJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 4Start Page: 427End Page: 439Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-239901Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd239901?id=journal-of-parkinsons-disease%2Fjpd239901Citation Count: 62
- Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s disease2018RESTRICTEDTitle: Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 136Issue #: 4Start Page: 621End Page: 639Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-018-1892-1Citation Count: 58